DI CHIARA, Tiziana
 Distribuzione geografica
Continente #
NA - Nord America 3.320
EU - Europa 1.808
AS - Asia 580
SA - Sud America 12
AF - Africa 8
OC - Oceania 1
Totale 5.729
Nazione #
US - Stati Uniti d'America 3.307
IT - Italia 875
CN - Cina 324
FI - Finlandia 252
UA - Ucraina 207
SG - Singapore 191
DE - Germania 120
IE - Irlanda 109
GB - Regno Unito 84
RU - Federazione Russa 30
SE - Svezia 29
FR - Francia 25
BE - Belgio 20
RO - Romania 20
IN - India 16
KR - Corea 15
CA - Canada 11
NL - Olanda 9
IR - Iran 8
TR - Turchia 8
BR - Brasile 7
CH - Svizzera 7
HK - Hong Kong 7
AT - Austria 6
CI - Costa d'Avorio 6
MK - Macedonia 6
PL - Polonia 3
CL - Cile 2
LU - Lussemburgo 2
MX - Messico 2
PH - Filippine 2
ZA - Sudafrica 2
AU - Australia 1
BG - Bulgaria 1
BH - Bahrain 1
CY - Cipro 1
EC - Ecuador 1
HR - Croazia 1
IL - Israele 1
LB - Libano 1
MN - Mongolia 1
MY - Malesia 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
TH - Thailandia 1
VA - Santa Sede (Città del Vaticano) 1
VE - Venezuela 1
VN - Vietnam 1
Totale 5.729
Città #
Fairfield 456
Chandler 335
Ashburn 298
Woodbridge 261
Seattle 189
Wilmington 186
Houston 172
Singapore 156
Ann Arbor 151
Palermo 126
Cambridge 123
Dublin 109
Jacksonville 103
Medford 88
Des Moines 82
Nanjing 63
Altamura 58
Princeton 55
Milan 50
New York 48
Lawrence 37
San Diego 36
Rome 35
Tulsa 30
Dearborn 28
Jinan 27
Beijing 26
Hebei 26
Boardman 25
Shenyang 25
Nanchang 23
Brussels 19
Florence 18
Santa Clara 18
Tianjin 15
Changsha 14
London 14
Ludwigshafen am Rhein 14
Seongnam 14
Falls Church 13
Verona 13
Auburn Hills 12
Kumar 12
Springfield 12
Grassobbio 11
Jiaxing 11
Columbus 10
Los Angeles 10
Hangzhou 9
San Mateo 9
Turin 9
Dallas 8
Izmir 8
Venice 8
Zhengzhou 8
Bologna 7
Ningbo 7
Ottawa 7
Phoenix 7
San Paolo di Civitate 7
Taizhou 7
Tehran 7
Abidjan 6
Frankfurt am Main 6
Guangzhou 6
Helsinki 6
Naples 6
Prilep 6
Prineville 6
San Pietro Vernotico 6
Amsterdam 5
Bremen 5
Chicago 5
Lanzhou 5
Munich 5
Napoli 5
Reggio Emilia 5
Torino 5
Castelnuovo Val Di Cecina 4
Catania 4
Central 4
Düsseldorf 4
Fuzhou 4
Latina 4
Messina 4
Mirano 4
Modena 4
Redwood City 4
Saint Petersburg 4
Taiyuan 4
Viareggio 4
Ancona 3
Battaglia Terme 3
Brescia 3
Buccinasco 3
Clearwater 3
Cornaredo 3
Formia 3
Hefei 3
Hong Kong 3
Totale 3.932
Nome #
Obesità e rischio cardiovascolare. 507
Antihypertensive and cardiovascular effects of combined blockade of renin-angiotensin system with ACE inhibitor and angiotensin II type 1 receptor blocker in hypertensive patients: a 24 week randomized controlled double-dummy trial. 180
A family with various symptomatology suggestive of Anderson-Fabry disease and a genetic polymorphism of alpha galactosidase A gene 168
Visceral obesity and metabolic syndrome: two faces of the same medal? 156
Hypoadiponectinemia, cardiometabolic comorbidities and left ventricular hypertrophy 147
May Adiponectin be considered as a Novel Cardiometabolic Biomarker? 146
Relationship between circulating E-selectin, DD genotype of angiotensin-converting-enzyme, and cardiovascular damage in central obese subjects 144
Inter-familial and intra-familial phenotypic variability in three Sicilian families with Anderson-Fabry disease. 144
Circulating adiponectin: a cardiometabolic marker associated with global cardiovascular risk 138
Improving efficacy of PubMed Clinical Queries for retrieving scientifically strong studies on treatment. 135
Hypoadiponectinemia: A Link between Visceral Obesity and Metabolic Syndrome. 135
Effects of cilazapril on renal haemodynamics and function in hypertensive patients: a randomised controlled study versus hydrochlorothiazide 135
The Relationship between the Transforming Growth Factor β1 T29C Gene Polymorphism and Left Ventricular Geometry and Function in Hypertensive Subjects 135
Take the wind out your salis: relationship among energy drink abuse, hypertension, and break-up of cerebral aneurysm 133
Genetics and gene therapy of anderson-fabry disease 131
Obesity related changes in cardiac structure and function: role of blood pressure and metabolic abnormalities. 131
Right ventricular diameter predicts all-cause mortality in heart failure with preserved ejection fraction 131
Hemostatic function in young subjects with central obesity: relationship with left ventricular function 128
Association between low education and higher global cardiovascular risk 128
Endothelial nitric oxide synthase gene polymorphisms and cardiovascular damage in hypertensive subjects: an Italian case-control study. 126
Plasma adiponectin: A contributing factor for cardiac changes in visceral obesity-associated hypertension 121
L’obesità fattore o co-fattore di rischio? 120
IgG4 Related Syndrome: Another Multiorgan Disease in the Interest Field of Internal Medicine. 116
Education and hypertension: impact on global cardiovascular risk 111
Left ventricular filling abnormalities and obesity-associated hypertension: relationship with overproduction of circulating transforming growth factor beta1. 110
Obesity and cardiovascular risk: the new public health problem of worldwide proportions. 104
Heredity and obesity-associated hypertension: impact of hormonal characteristics and left ventricular mass. J Hypertens 103
Efficacy of dulaglutide on vascular health indexes in subjects with type 2 diabetes: a randomized trial 99
Effetti cardioprotettivi del Blocco del Sistema Renina-Angiotensina-Aldosterone tramite l’associazione ACE-inibitore – Sartani: Relazione con i livelli circolanti di Transforming Growth Factor ß1. 98
DIASTOLIC DYSFUNCTION AND CENTRAL OBESITY RELATED HYPERTENSION: ROLE OF TRASFORMING GROWTH FACTOR BETA-1 98
Effect of dual blockade of renin-angiotensin system on TGF beta 1 and left ventricular structure and function in hypertensive patients 90
Obesity: a main factor of metabolic syndrome? 90
Prevalence of obesity and ischaemic heart disease in hypertensive subjects 90
Can Be miR-126-3p a Biomarker of Premature Aging? An Ex Vivo and In Vitro Study in Fabry Disease 87
Associazione tra elevate livelli circolanti di Transforming growth factor ß1 (TGF ß1) ed alterato riempimento ventricolare sinistro in una popolazione di soggetti ipertesi. 84
Central obesity and hypertensive renal disease: association between higher levels of BMI, circulating transforming growth factor beta1 and urinary albumin excretion. 72
Associazione tra elevati livelli circolanti di Transforming growth factor ß1 (TGF ß1) e alterato riempimento ventricolare sinistro in una popolazione di soggetti ipertesi. 71
DIASTOLIC DYSFUNCTION AND CENTRAL OBESITY RELATED HYPERTENSION: ROLE OF TRANSFORMING GROWTH FACTOR BETA-1 71
Transforming growth factor beta1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: a 24-week randomized controlled trial 69
Transforming growth factor beta1 T29C gene polymorphism and hypertension: relationship with cardiovascular and renal damage. 68
Sindrome Metabolica 65
Pathogenesis and molecular mechanisms of anderson–fabry disease and possible new molecular addressed therapeutic strategies 64
Effects of intravenous furosemide plus small-volume hypertonic saline solutions on markers of heart failure 63
Micro-albuminuria in obese subjects: relationship among body fat distribution, blood pressure and left ventricular structure and function. 62
Transforming growth factor beta1 ed effetto nefroprotettivo dell’associazione ACE-inibitori-AT1 antagonista in soggetti ipertesi con iniziale danno renale 61
La terapia dietetica nell’insufficienza renale cronica. 60
Nutrizione,sovrappeso e sindrome metabolica 57
Scompenso cardiaco da disfunzione diastolica. 56
A case of infective colitis due to Yersinia enterocolitica complicated by microliver abscesses mimicking multiple liver occult metastases: a case report 54
null 51
Sindrome metabolica: fatti e compromessi. 50
Assessment of heart rate variability (HRV) in subjects with type 2 diabetes mellitus with and without diabetic foot: correlations with endothelial dysfunction indices and markers of adipo-inflammatory dysfunction 50
Iperuricemia: significato clinico e nuove prospettive di trattamento 42
Pathogenetic Mechanisms of Hypertension–Brain-Induced Complications: Focus on Molecular Mediators 40
Metabolic memory in diabetic foot syndrome (dfs): epigenetic changes of the expression of micro-rnas and single nucleotide polymorphisms (snps) frequency in a cohort of diabetic patients with and without foot ulceration and correlation with indices of endothelial and adipo-inflammatory dysfunction 38
Il paziente iperteso ad alto rischio cadiovascolare 31
Vascular health in subjects with rheumatoid arthritis: assessment of endothelial function indices and serum biomarkers of vascular damage 28
Transforming growth factor β1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: A 24-week randomized controlled trial 27
Molecular Mechanisms of Inflammasome in Ischemic Stroke Pathogenesis 25
Metabolic memory in diabetic foot syndrome (DFS): MICRO-RNAS, single nucleotide polymorphisms (SNPs) frequency and their relationship with indices of endothelial function and adipo-inflammatory dysfunction 15
Transforming growth factor β1 T29C gene polymorphism and hypertension: Relationship with cardiovascular and renal damage 15
Mediterranean diet effects on vascular health and serum levels of adipokines and ceramides 14
Paraneoplastic Cerebellar Degeneration Associated with Breast Cancer: A Case Report and a Narrative Review 9
Totale 6.027
Categoria #
all - tutte 24.020
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.020


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020722 0 0 0 0 0 152 135 72 133 47 128 55
2020/2021755 32 74 45 63 64 24 73 45 107 70 92 66
2021/2022733 28 129 16 30 68 27 40 48 78 91 44 134
2022/20231.053 87 168 36 108 102 154 75 79 146 13 44 41
2023/2024487 27 61 21 39 39 99 42 33 8 18 17 83
2024/2025358 26 78 59 109 52 34 0 0 0 0 0 0
Totale 6.027